Business Description

EGF Theramed Health Corp
NAICS : 621399
SIC : 8683
ISIN : CA30050R1064
Description
EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. The company explores many other medical areas including weight loss, skincare and heart disease.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -6.22 | |||||
Debt-to-Equity | -1.17 | |||||
Debt-to-EBITDA | -5.27 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 92.2 | |||||
3-Year EPS without NRI Growth Rate | 81.4 | |||||
3-Year FCF Growth Rate | 84.3 | |||||
3-Year Book Growth Rate | 41.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 89.2 | |||||
9-Day RSI | 71.37 | |||||
14-Day RSI | 58.06 | |||||
3-1 Month Momentum % | -82.39 | |||||
6-1 Month Momentum % | -58.42 | |||||
12-1 Month Momentum % | -76.02 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.07 | |||||
Quick Ratio | 0.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -124.8 | |||||
Shareholder Yield % | -19.45 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -142.01 | |||||
ROIC % | -25.95 | |||||
3-Year ROIIC % | -176.72 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -2.91 | |||||
EV-to-EBITDA | -2.91 | |||||
EV-to-FCF | -5.43 | |||||
Earnings Yield (Greenblatt) % | -34.36 | |||||
FCF Yield % | -13.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EVAHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EGF Theramed Health Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.025 | ||
Beta | 0.83 | ||
3-Year Sharpe Ratio | 0.53 | ||
3-Year Sortino Ratio | 1.43 | ||
Volatility % | 337.46 | ||
14-Day RSI | 58.06 | ||
14-Day ATR ($) | 0.007355 | ||
20-Day SMA ($) | 0.05042 | ||
12-1 Month Momentum % | -76.02 | ||
52-Week Range ($) | 0.011 - 0.2905 | ||
Shares Outstanding (Mil) | 11.39 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EGF Theramed Health Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EGF Theramed Health Corp Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
EGF Theramed Health Corp Frequently Asked Questions
What is EGF Theramed Health Corp(EVAHF)'s stock price today?
The current price of EVAHF is $0.08. The 52 week high of EVAHF is $0.29 and 52 week low is $0.01.
When is next earnings date of EGF Theramed Health Corp(EVAHF)?
The next earnings date of EGF Theramed Health Corp(EVAHF) is .
Does EGF Theramed Health Corp(EVAHF) pay dividends? If so, how much?
EGF Theramed Health Corp(EVAHF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |